Angiogenesis and lipoxins

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 271-275

  Fierro, Iolanda M ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI 16 (4 FLUORO)PHENOXYLIPOXIN A 4; ACETYLSALICYLIC ACID; ASPIRIN TRIGGERED LIPOXIN; CYCLOOXYGENASE 2 INHIBITOR; LIPOXIN; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; UNCLASSIFIED DRUG;

ANGIOGENESIS; CAPILLARY; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; ENANTIOMER; ENDOTHELIUM CELL; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 24344477181     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.016     Document Type: Article

References (50)

1. J. Folkman, and Y. Shing Angiogenesis J. Biol. Chem. 267 1992 10931 10934
2. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
3. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
4. A.D. Arenberg, and R.M. Strieter Angiogenesis J.I. Gallin R. Snyderman Inflammation: Basic Principles and Clinical Correlates 1999 Lippincott Williams & Wilkins Philadelphia 851 864
5. M. Ziche, S. Donnini, and L. Morbidelli Development of new drugs in angiogenesis Curr. Drug Targets 5 2004 485 493
6. R.M. Strieter, J.A. Belperio, R.J. Phillips, and M.P. Keane CXC chemokines in angiogenesis of cancer Semin. Cancer Biol. 14 2004 195 200
7. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin. Oncol. 29 2002 15 18
8. D. Ausprunk, and J. Folkman Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis Microvasc. Res. 14 1977 53 65
9. D. Nie, K. Tang, K. Szekeres, L. Li, and K.V. Honn Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications Ann. N.Y. Acad. Sci. 905 2000 165 176
10. D. Nie, M. Che, D. Grignon, D. Tang, and K.V. Honn Role of eicosanoids in prostate cancer progression Cancer Metastasis Rev. 20 2001 195 206
11. M. Kandouz, D. Nie, G.P. Pidgeon, S. Krishnamoorthy, K.R. Maddipati, and K.V. Honn Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells Prostaglandins Other Lipid Mediat. 71 2003 189 204
12. M. Romano, A. Catalano, and M. Nutini 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor FASEB J. 15 2001 2326 2336
13. D. Nie, and K.V. Honn Eicosanoid regulation of angiogenesis in tumors Semin. Thromb. Hemost. 30 2004 119 125
14. M.M. Höpper, N.F. Voelkel, and T.O. Bates Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP Am. J. Respir. Cell. Mol. Biol. 17 1997 748 756
15. 2 stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways Biochem. Biophys. Res. Commun. 286 2001 923 928
16. 2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts Br. J. Pharmacol. 136 2002 287 295
17. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis Cancer Res. 59 1999 4574 4577
18. 2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis Biochem. Biophys. Res. Commun. 267 2000 245 251
19. J.E. Nor, J. Christensen, and J. Liu Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth Cancer Res. 61 2001 2183 2188
20. S. Dimmeler, and A.M. Zeiher Akt takes center stage in angiogenesis signaling Circ. Res. 86 2000 4 5
21. A.R. Nelson, B. Fingleton, M.L. Rothenberg, and L.M. Matrisian Matrix metalloproteinases: biologic activity and clinical implications J. Clin. Oncol. 18 2000 1135 1149
22. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat. Med. 8 2002 289 293
23. M. Stolina, S. Sharma, and Y. Lin Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J. Immunol. 164 2000 361 370
24. M.I. Shtivelband, H.S. Juneja, S. Lee, and K.K. Wu Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression J. Thromb. Haemost. 1 2003 2225 2233
25. D. Wang, and R.N. DuBois Cyclooxygenase-2: a potential target in breast cancer Semin. Oncol. 31 2004 64 73
26. J. Vane Aspirin and other anti-inflammatory drugs Thorax 55 2000 S3 S9
27. J. Clària, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc. Natl. Acad. Sci. USA 92 1995 9475 9479
28. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostaglandins Other Lipid Mediat. 68-69 2002 433 455
29. 4 ELISA J. Pharmacol. Exp. Ther. 287 1998 779 790
30. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
31. 4 and inhibits thromboxane in a randomized human trial Proc. Natl. Acad. Sci. USA 101 2004 15178 15183
32. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad. Sci. USA 96 1999 8247 8252
33. 4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release J. Exp. Med. 187 1998 1285 1294
34. 4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes Proc. Natl. Acad. Sci. USA 99 2002 13266 13271
35. 4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases J. Immunol. 164 2000 2660 2666
36. S.H. Jee, C.Y. Chu, and H.C. Chiu Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways J. Invest. Dermatol. 123 2004 1169 1175
37. 4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis J. Exp. Med. 189 1999 1923 1930
38. O.V. Volpert, T. Fong, and A.E. Koch Inhibition of angiogenesis by interleukin 4 J. Exp. Med. 188 1998 1039 1046
39. N. Ferrara, H. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
40. 4 J. Pharmacol. Exp. Therap. 300 2002 385 392
41. T.J. Mitchison, and L.P. Cramer Actin-based cell motility and cell locomotion Cell 84 1996 371 379
42. J. Claria, M.H. Lee, and C.N. Serhan Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation Mol. Med. 2 1996 583 596
43. 4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors J. Biol. Chem. 275 2000 27566 27575
44. 4 receptor J.J. Oppenheim M. Feldmann S.K. Durum T. Hirano J. Vilcek N.A. Nicola Cytokine Reference 2000 Academic Press London 2219 2233
45. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
46. 4 and regulation of vascular and inflammatory responses Am. J. Pathol. 158 2001 3 9
47. R.S. Cotran, V. Kumar, and S.L. Robbins Inflammation and repair R.S. Cotran V. Kumar S.L. Robbins Robbins Pathologic Basis of Disease 1994 W.B. Saunders Philadelphia 51 92
48. C.N. Serhan Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53 1997 107 137
49. P.R. Colville-Nash, C.A. Alam, I. Appleton, J.R. Brown, M.P. Seed, and D. Willoughby The pharmacological modulation of angiogenesis in chronic granulomatous inflammation J. Pharmacol. Exp. Ther. 274 1995 1463 1472
50. J.L. Masferrer, A. Koki, and K. Seibert COX-2 inhibitors. A new class of antiangiogenic agents Ann. N.Y. Acad. Sci. 889 1999 84 86